Business Wire

EUROPEAN DYNAMICS welcomes a Strategic Minority Investment from CAPZA and Abry Partners

10.4.2025 13:02:00 CEST | Business Wire | Press release

Share

EUROPEAN DYNAMICS (“ED” or “the Company”), a global, market leading provider of eGovernment software and digital transformation services to Governments and International Institutions, announced today a minority investment led by CAPZA (investing through its flagship Flex Equity Mid-Market 2 fund) and joined by Abry Partners (“Abry”, investing through its Senior Equity Fund, ASE VI, LP) (together “the Investors”).

The Investors will support ED’s growth strategy together with its founder and Chief Executive Officer, Constantinos Velentzas, who retains a significant majority of the Company’s share capital. This investment marks the Company’s first partnership with financial investors since its inception.

CAPZA1, who will be the lead investor in the transaction, is an established private investment platform across private debt and private equity in Europe with more than €9.1 billion of assets under management (AuM)2. CAPZA is part of AXA Investment Managers Alts (“AXA IM Alts”), a global leader in alternative investments with over €186 billion of AuM.3 Through its Flex Equity Mid-Market 2 fund, CAPZA invests tickets of up to €150 million in European and global leaders with strong growth potential.

Abry is a leading sector-focused North American private equity firm which invests across the capital structure managing $17 billion of assets across several investment strategies.

Founded in 1994, the Company has become a leading eGovernment and digital transformation partner for the public sector, recognised for its deep expertise and ability to leverage technology and data to drive innovation. ED has also developed and commercialises a suite of market leading software products specifically tailored to core eGovernment activities (notably in the fields of customs, taxation, procurement, financial markets and IP management).

With a staff of c. 1,200 across 7 main international operating subsidiaries, the Company works with c. 100 clients globally including Federal Governments, European Institutions & International Organisations in more than 30 countries and 4 continents. ED has established a multidisciplinary Technology Centre in Greece, and prepares its expansion in France, the Nordics, DACH and the USA. In this context ED is intensifying its recruitment plan, aiming at hiring 800 technology experts over the next few years (more than 50% of these new posts will be based in Greece). In addition, the Company negotiates partnerships with universities and academic centers in Europe and in the USA.

The Company has experienced significant organic growth, notably driven by the growing needs of institutions and government bodies’ IT solutions to enhance operational efficiency and ensure compliance with regulatory constraints. The partnership with the Investors will accelerate ED’s expansion within and outside Europe, while it will also support through the necessary investment, innovative product development and strategic M&A.

Completion of the transaction is expected by summer 2025 and is subject to customary closing conditions and approvals.

Constantinos Velentzas, Founder and Chief Executive Officer, EUROPEAN DYNAMICS, said: “We are thrilled that CAPZA and Abry are investing in ED as minority partners, which proves the embedded value of our Company. This partnership reflects a shared conviction in our strategic model as well as the common ambition of a leadership position in the critical and ever-evolving landscape of the eGovernment sector. Today’s announcement is also a testament to the hard work of everyone at ED, our three decades of organic growth and the opportunity that lies ahead. With the Investors, we can grow our organic offerings, accelerate our international expansion plans and further develop our ability to innovate, bringing our services and products to more clients around the world.”

Jess Wizman, Partner Flex Equity Mid-Market at CAPZA, said: “We are proud to partner with EUROPEAN DYNAMICS, a market leader in digital transformation for Governments, European and International Institutions. CAPZA has a strong track-record in supporting high-growth software and IT services companies, and we were particularly impressed by ED’s deep domain expertise, mission-critical solutions, and international reach. We are excited to support Constantinos Velentzas and the management team in ED’s next growth chapter, notably in key markets like France and in strategic sectors including Defense.”

Tyler Wick, Co-Head of Abry Senior Equity Fund at Abry Partners, said: “Constantinos and the ED management team have built a world-class software and digital transformation platform dedicated to providing complex and mission critical solutions to the public sector. We have extensive experience partnering with government technology companies in North America and Europe and we believe that EUROPEAN DYNAMICS is well positioned to expand its global leadership position. Abry is thrilled to partner with the Company and support the management team in this next phase of growth, including expansion into North America and into rapidly growing categories such as artificial intelligence.”

Deal Participants

Company
Financial Advisor: Houlihan Lokey
Lawyers: Ashurst LLP and Lambadarios Law Firm
Vendor Due Diligence (Financial, Tax, and Commercial): PwC

CAPZA
Deal team: Jess Wizman, Antoine Forgeard, Roxane des Jamonières, Mathieu Moreau
Lawyers: Paul Hastings
M&A: Bryan Garnier & Co
Due Diligence

  • Strategic: PMP
  • Financial: Alvarez & Marsal
  • Legal, Tax and Social: Grant Thornton
  • Tech, ESG: Eleven

Abry Partners
Deal team: Tyler Wick, Rashard Green, Zaid Khanbozai, Ryan McCarthy
Lawyers: Kirkland & Ellis LLP
M&A: William Blair
Due Diligence

  • Strategic: Loenberg Consulting
  • Financial: Alvarez & Marsal
  • Tax: Ernst & Young

About CAPZA

Created in 2004, CAPZA is an established European private investment platform.

With more than €9.1 billion of assets, CAPZA puts its experience and passion for investing at the service of investors worldwide with its platform of 6 complementary investment strategies: Flex Equity, Flex Equity Mid-Market, Growth Tech, Transition4, Private Debt, and Artemid5.

CAPZA offers financing solutions to companies at every stage of their development. Its unique platform allows CAPZA to support companies over the long term by providing them with custom-made financing solutions (majority equity, minority equity, subordinated debt, senior debt, etc.). CAPZA is a generalist but has built up strong expertise in supporting companies in the health, technology and services sectors.

CAPZA Group has more than 115 employees based in Paris, Munich, Madrid, Milan and Amsterdam, and is part of AXA IM Alts, one of the global leaders in alternative investments with €186 billion in assets under management.

More information about CAPZA: https://capza.co

About Abry Partners

Abry Partners is one of the most experienced and successful sector-focused private equity investment firms in North America. Since its founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages $17 billion of assets across several fund strategies.

More information about Abry Partners: www.abry.com

Disclaimer

This document is aimed solely at the media and is for information purposes only. The opinions expressed here are the views of the author and do not constitute investment advice. This is not a recommendation to purchase, sell or subscribe to financial instruments, an offer to sell investment funds or an offer of financial services. This press release is as dated. They do not necessarily represent the views of any company within the AXA Investment Managers Group and may be subject to change without notice. This does not constitute a Financial Promotion. This is for information purposes only. No financial decisions should be made on the basis of the information provided. Past performance is not necessarily representative of future results: performance is not constant over time and the value of investments may fall as well as rise.

_____________________________

1 Atalante (commercial name CAPZA)

2 Including assets managed by a third party and advised by Artemid SAS. Based on valuations as of 31/12/2024.

3 Source: AXA IM Alts data (unaudited) as at 31 December 2024.

4 The funds of the CAPZA Transition range are managed by the asset management company CAPZA, and advised by CAPZA Transition SAS which has financial investment advisor status (CIF in France), is registered under the Orias under the number 18001601 since the 03/23/2018.

5 The funds of the Artemid range are managed by the asset management company CAPZA and advised by Artemid SAS, which is a subsidiary of CAPZA and has financial investment advisor status (CIF in France). Artemid SAS is registered by the Orias under the number 14003497 since the 05/28/2014.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250409295704/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye